Evidence map›Paper›PMID 24493859›Full record

ArticleSexually transmitted infections2014

Risk factors for rectal lymphogranuloma venereum in gay men: results of a multicentre case-control study in the U.K.

N Macdonald, A K Sullivan, P French, J A White, G Dean, A Smith, A J Winter, S Alexander, C Ison, H Ward

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Sexually transmitted infections, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Lymphogranuloma venereum: an emerging problem in Poland.Postepy dermatologii i alergologii · 2022
    Review
  5. Article
  6. Microbial genomics · 2019
    Article
  7. Article
  8. Lymphogranuloma venereum in Quebec: Re-emergence among men who have sex with men.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2018
    Article
  9. Article
  10. Article
  11. Approach to lymphogranuloma venereum.Canadian family physician Medecin de famille canadien · 2016
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

N MacdonaldDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.
A K SullivanChelsea and Westminster NHS Foundation Trust, London, UK.
P FrenchMortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK.
J A WhiteGuy's and St Thomas' NHS Foundation Trust, London, UK.
G DeanBrighton & Sussex University Hospitals NHS Trust, Brighton, UK.
A SmithJefferiss Wing Centre for Sexual Health, Imperial College Healthcare NHS Trust, London, UK.
A J WinterSandyford Sexual Health Services, Glasgow, UK.
S AlexanderSexually Transmitted Bacterial Reference Unit, Public Health England, London, UK.
C IsonSexually Transmitted Bacterial Reference Unit, Public Health England, London, UK.
H WardDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.
Imperial College London · GBPublic Health England · GBChelsea and Westminster Hospital NHS Foundation Trust · GBGuy's and St Thomas' NHS Foundation Trust · GBImperial College Healthcare NHS Trust · GBLothian Sexual Health · GBMortimer Market Centre · GBUniversity Hospitals Sussex NHS Foundation Trust · GB

Funding

Medical Research Council G0601699
6 · The paper itself

Abstract

objectiveTo identify risk factors for rectal lymphogranuloma venereum (rLGV) in men who have sex with men (MSM).

designA case-control study at 6 U.K. hospitals compared MSM with rLGV (cases) with rLGV-negative controls: MSM without potential rLGV symptoms (CGa) and separately, MSM with such symptoms (CGs).

methodsBetween 2008 and 2010, there were 90 rLGV cases, 74 CGa and 69 CGs recruited. Lifestyles and sexual behaviours in the previous 3 months were reported using internet-based computer-assisted self-interviews. Logistic regression was used to investigate factors associated with rLGV.

resultsCases were significantly more likely to be HIV-positive (89%) compared with CGa (46%) and CGs (64%). Independent behavioural risks for rLGV were: unprotected receptive anal intercourse (adjusted OR (AOR)10.7, 95% CI 3.5 to 32.8), fisting another (AOR=6.7, CI 1.8 to 25.3), sex under the influence of gamma-hydroxybutyrate (AOR=3.1, CI 1.3 to 7.4) and anonymous sexual contacts (AOR=2.7, CI 1.2 to 6.3), compared with CGa; unprotected insertive anal intercourse (AOR=4.7, CI 2.0 to 10.9) and rectal douching (AOR=2.9 CI 1.3 to 6.6), compared with CGs. An incubation period from exposure to symptoms of 30 days was indicated.

conclusionsUnprotected receptive anal intercourse is a key risk factor for rectal LGV with the likelihood that rectal-to-rectal transmission is facilitated where insertive anal sex also occurs. The association between HIV and rLGV appears linked to HIV-positive men seeking unprotected sex with others with the same HIV status, sexual and drug interests. Such men should be targeted for frequent STI screening and interventions to minimise associated risks.

Indexed as

AdultCase-Control StudiesHIV InfectionsHomosexuality, MaleHumansLogistic ModelsLymphogranuloma VenereumMaleMiddle AgedMultivariate AnalysisProspective StudiesRectal DiseasesRisk FactorsSexual BehaviorSodium OxybateTherapeutic IrrigationSodium OxybateChlamydia TrachomatisGay MenHIVLymphogranuloma VenereumSexual Behaviour

Identifiers

PMID24493859
PMCPMC4033107
OpenAlexW2108288690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.